MARELYS TORRES ABREU: Open Payments
NPI 1023649274 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,469 in 123 payments from 23 companies in 2025. Trend: 2023 $2,386 · 2024 $2,448 · 2025 $2,469
Food & beverage: $2,359Education: $109
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $436 |
| Janssen Biotech, Inc. | 16 | $408 |
| Madrigal Pharmaceuticals | 15 | $287 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 19 | $267 |
| Celltrion USA Inc. | 5 | $208 |
| Ardelyx, Inc. | 11 | $180 |
| EVOKE PHARMA, INC. | 4 | $74 |
| Aimmune Therapeutics, Inc. | 3 | $71 |
| Braintree Laboratories, Inc. | 3 | $70 |
| Lilly USA, LLC | 3 | $59 |
Products named: TREMFYA, REZDIFFRA, XIFAXAN, LINZESS, VEGZELMA, IBSRELA, RINVOQ, GIMOTI.
Industry payments across FL — which companies pay providers there.
